Clinical Trials in Pittsburgh

Showing 1681-1700 of 21,047 trials

A Study of Azenosertib (ZN-c3) in Participants With Solid Tumors

NCT04158336

This is a Phase 1 open-label, multicenter study of ZN-c3 (also known as Azenosertib) monotherapy which consists of Dose Escalation, a Food Effect Cohort, and Dose Expansion.

Solid Tumor

K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc274 participantsStarted Nov 2019

Tucson, Arizona, United States • Newport Beach, California, United States • Chicago, Illinois, United States +5 more locations

TERMINATEDPhase 1< 1 mile

Phase 1 Study of Shattuck Labs (SL)-172154 in Subjects With MDS or AML

NCT05275439

SL03-Old Hundred(OHD)-104 is designed as a Phase 1a/1b open label, trial to evaluate the safety, pharmacokinetics (PK), pharmacodynamic (PD), and preliminary efficacy of SL-172154 monotherapy as well as in combination with azacitidine or in combination with Azacitidine and Venetoclax.

Acute Myeloid LeukemiaMyelodysplastic Syndromes

Shattuck Labs, Inc.106 participantsStarted Mar 2022

Duarte, California, United States • Los Angeles, California, United States • New Haven, Connecticut, United States +20 more locations

A Study of Azenosertib (ZN-c3) in Participants With Solid Tumors

Phase 1 Study of Shattuck Labs (SL)-172154 in Subjects With MDS or AML

Find Trials by Condition in Pittsburgh

Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System

Improving Infant Hydrocephalus Outcomes in Uganda

A Study of DF6002 Alone and in Combination With Nivolumab

HCMR Re-Imaging Study

SakuraBead Used as Resorbable Embolic for Genicular Artery Embolization

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

A Study of Azenosertib (ZN-c3) and Niraparib in Subjects With Platinum-Resistant Ovarian Cancer

Topical Ketotifen 0.25% for Secondary Vestibulodynia

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

Comparison of Fulvestrant (FASLODEX™) 250 mg and 500 mg in Postmenopausal Women With Oestrogen Receptor Positive Advanced Breast Cancer Progressing or Relapsing After Previous Endocrine Therapy.

A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss

PRISM Intervention Study

Predictors of Mental Health in Men With Prostate Cancer Undergoing a Patient Empowerment Program

Selinexor and Pacritinib in JAK Inhibitor-naïve MF Patients With Cytopenias

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

Safety and Performance Study of the FAST-FIX FLEX System for Meniscal Repairs and Meniscal Transplantations

Safety and Efficacy of AON-D21 in Severe Community-Acquired Pneumonia.

REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis